January 10, 2008 - ThromboVision Inc., a biomedical diagnostics company, has initiated clinical trials of its ThromboGuide (T-Guide) Platelet Function Monitor. Enrollment and data collection are under way at four key research institutes as it prepares to apply for 510(k) FDA clearance.
The T-Guide consists of a disposable test kit and a point-of-care base unit. The system is designed to help physicians individualize antiplatelet therapy that they use to prevent heart attacks, strokes and stent occlusions.